{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361137043678861824.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1161/hypertensionaha.108.122721"}},{"identifier":{"@type":"URI","@value":"https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.108.122721"}},{"identifier":{"@type":"PMID","@value":"19047581"}}],"dc:title":[{"@value":"“Pulse” Treatment With High-Dose Angiotensin Blocker Reverses Renal Arteriolar Hypertrophy and Regresses Hypertension"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>One ultimate goal of hypertension therapy is to cause permanent reversal (“regression”) of already established hypertension. Our aim was to examine whether high-dose “pulse” treatment with a renin-angiotensin system inhibitor could cause regression of established hypertension and to link this action to reversal of arteriolar hypertrophy and changes in vascular matrix metalloproteinase activities. First, 16-week-old male spontaneously hypertensive rats (n=60) were pulse treated for 2 weeks with high-dose angiotensin-converting enzyme inhibitor (enalapril), angiotensin receptor blocker (candesartan), calcium channel blocker (nifedipine), or vasodilator (hydralazine) with or without salt restriction, and the long-term effects on blood pressure were examined. Second, spontaneously hypertensive rats were treated with angiotensin receptor blocker or calcium channel blocker, and the effects on renal gene expressions, arteriolar structure, and vascular matrix metalloproteinase were compared. Treatment of spontaneously hypertensive rats with different antihypertensive agents caused apparently similar reductions in blood pressure during the course of the pulse treatment, within the limitations of the tail-cuff method. After cessation of medications, blood pressure in the rats treated with renin-angiotensin system inhibitor remained reduced by >30 to 40 mm Hg for 4 months. No such effect was seen with calcium channel blocker or vasodilator. The 2-week angiotensin receptor blocker treatment induced a marked reversal of the arteriolar hypertrophy specifically in the small (30 to 100 μm) renal arterioles, together with increased expression and activity of matrix metalloproteinase-13. In conclusion, transient high-dose pulse treatment with angiotensin receptor blocker caused changes in vascular matrix metalloproteinase activity, specific reversal of renal arteriolar hypertrophy, and regression of hypertension in spontaneously hypertensive rats.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381137043678861826","@type":"Researcher","foaf:name":[{"@value":"Kimiko Ishiguro"}],"jpcoar:affiliationName":[{"@value":"From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan."}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326222843264","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"60445294"},{"@type":"NRID","@value":"1000060445294"},{"@type":"NRID","@value":"9000361694539"},{"@type":"NRID","@value":"9000362197852"},{"@type":"NRID","@value":"9000394485750"},{"@type":"NRID","@value":"9000016399282"},{"@type":"NRID","@value":"9000309570151"},{"@type":"NRID","@value":"9000368921233"},{"@type":"NRID","@value":"9000006190059"},{"@type":"NRID","@value":"9000257811298"},{"@type":"NRID","@value":"9000375894283"},{"@type":"NRID","@value":"9000009728569"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0137387"}],"foaf:name":[{"@value":"Kaori Hayashi"}],"jpcoar:affiliationName":[{"@value":"From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan."}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043678861824","@type":"Researcher","foaf:name":[{"@value":"Hiroyuki Sasamura"}],"jpcoar:affiliationName":[{"@value":"From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan."}]},{"@id":"https://cir.nii.ac.jp/crid/1381137043678861828","@type":"Researcher","foaf:name":[{"@value":"Yusuke Sakamaki"}],"jpcoar:affiliationName":[{"@value":"From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan."}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801185875456","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40252457"},{"@type":"NRID","@value":"1000040252457"},{"@type":"NRID","@value":"9000018534315"},{"@type":"NRID","@value":"9000021491008"},{"@type":"NRID","@value":"9000402234722"},{"@type":"NRID","@value":"9000311507181"},{"@type":"NRID","@value":"9000345333639"},{"@type":"NRID","@value":"9000361694545"},{"@type":"NRID","@value":"9000362197860"},{"@type":"NRID","@value":"9000314379147"},{"@type":"NRID","@value":"9000399370854"},{"@type":"NRID","@value":"9000257804537"},{"@type":"NRID","@value":"9000257804448"},{"@type":"NRID","@value":"9000019089305"},{"@type":"NRID","@value":"9000292181807"},{"@type":"NRID","@value":"9000001179546"},{"@type":"NRID","@value":"9000021884274"},{"@type":"NRID","@value":"9000257776534"},{"@type":"NRID","@value":"9000257805381"},{"@type":"NRID","@value":"9000002132665"},{"@type":"NRID","@value":"9000021338381"},{"@type":"NRID","@value":"9000406227156"},{"@type":"NRID","@value":"9000258727078"},{"@type":"NRID","@value":"9000402138691"},{"@type":"NRID","@value":"9000016813965"},{"@type":"NRID","@value":"9000024563967"},{"@type":"NRID","@value":"9000345260169"},{"@type":"NRID","@value":"9000399511638"},{"@type":"NRID","@value":"9000391395847"},{"@type":"NRID","@value":"9000380968345"},{"@type":"NRID","@value":"9000257808381"},{"@type":"NRID","@value":"9000261692511"},{"@type":"NRID","@value":"9000001899030"},{"@type":"NRID","@value":"9000018980527"},{"@type":"NRID","@value":"9000259322309"},{"@type":"NRID","@value":"9000389446461"},{"@type":"NRID","@value":"9000368940218"},{"@type":"NRID","@value":"9000257803895"},{"@type":"NRID","@value":"9000257811576"},{"@type":"NRID","@value":"9000412351891"},{"@type":"NRID","@value":"9000019146027"},{"@type":"NRID","@value":"9000392738866"},{"@type":"NRID","@value":"9000257811301"},{"@type":"NRID","@value":"9000257809919"},{"@type":"NRID","@value":"9000406384318"},{"@type":"NRID","@value":"9000259322294"},{"@type":"NRID","@value":"9000020431720"},{"@type":"NRID","@value":"9000243886384"},{"@type":"NRID","@value":"9000283100512"},{"@type":"NRID","@value":"9000283344110"},{"@type":"NRID","@value":"9000257777418"},{"@type":"NRID","@value":"9000347362672"},{"@type":"NRID","@value":"9000345260103"},{"@type":"NRID","@value":"9000345378594"},{"@type":"NRID","@value":"9000257809498"},{"@type":"NRID","@value":"9000257804838"},{"@type":"NRID","@value":"9000390932102"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0131073"}],"foaf:name":[{"@value":"Hiroshi Itoh"}],"jpcoar:affiliationName":[{"@value":"From the Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0194911X"},{"@type":"EISSN","@value":"15244563"}],"prism:publicationName":[{"@value":"Hypertension"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2009-01","prism:volume":"53","prism:number":"1","prism:startingPage":"83","prism:endingPage":"89"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://www.ahajournals.org/doi/full/10.1161/HYPERTENSIONAHA.108.122721"}],"createdAt":"2008-12-01","modifiedAt":"2024-05-13","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Nifedipine","dc:title":"Nifedipine"},{"@id":"https://cir.nii.ac.jp/all?q=Vasodilator%20Agents","dc:title":"Vasodilator Agents"},{"@id":"https://cir.nii.ac.jp/all?q=Tetrazoles","dc:title":"Tetrazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Angiotensin-Converting%20Enzyme%20Inhibitors","dc:title":"Angiotensin-Converting Enzyme Inhibitors"},{"@id":"https://cir.nii.ac.jp/all?q=Blood%20Pressure","dc:title":"Blood Pressure"},{"@id":"https://cir.nii.ac.jp/all?q=Kidney","dc:title":"Kidney"},{"@id":"https://cir.nii.ac.jp/all?q=Rats,%20Inbred%20WKY","dc:title":"Rats, Inbred WKY"},{"@id":"https://cir.nii.ac.jp/all?q=Enalapril","dc:title":"Enalapril"},{"@id":"https://cir.nii.ac.jp/all?q=Rats,%20Inbred%20SHR","dc:title":"Rats, Inbred SHR"},{"@id":"https://cir.nii.ac.jp/all?q=Matrix%20Metalloproteinase%2013","dc:title":"Matrix Metalloproteinase 13"},{"@id":"https://cir.nii.ac.jp/all?q=Renin","dc:title":"Renin"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Aldosterone","dc:title":"Aldosterone"},{"@id":"https://cir.nii.ac.jp/all?q=Dose-Response%20Relationship,%20Drug","dc:title":"Dose-Response Relationship, Drug"},{"@id":"https://cir.nii.ac.jp/all?q=Biphenyl%20Compounds","dc:title":"Biphenyl Compounds"},{"@id":"https://cir.nii.ac.jp/all?q=Hypertrophy","dc:title":"Hypertrophy"},{"@id":"https://cir.nii.ac.jp/all?q=Calcium%20Channel%20Blockers","dc:title":"Calcium Channel Blockers"},{"@id":"https://cir.nii.ac.jp/all?q=Hydralazine","dc:title":"Hydralazine"},{"@id":"https://cir.nii.ac.jp/all?q=Rats","dc:title":"Rats"},{"@id":"https://cir.nii.ac.jp/all?q=Arterioles","dc:title":"Arterioles"},{"@id":"https://cir.nii.ac.jp/all?q=Disease%20Models,%20Animal","dc:title":"Disease Models, Animal"},{"@id":"https://cir.nii.ac.jp/all?q=Hypertension","dc:title":"Hypertension"},{"@id":"https://cir.nii.ac.jp/all?q=Benzimidazoles","dc:title":"Benzimidazoles"},{"@id":"https://cir.nii.ac.jp/all?q=Angiotensin%20II%20Type%201%20Receptor%20Blockers","dc:title":"Angiotensin II Type 1 Receptor Blockers"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232044958336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Decreased KAT5 Expression Impairs DNA Repair and Induces Altered DNA Methylation in Kidney Podocytes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233405815424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004233406658816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical significance of ‘cardiometabolic memory’: a systematic review of randomized controlled trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168887512576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283691771860352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693782918528","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183418163072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Organ memory: a key principle for understanding the pathophysiology of hypertension and other non-communicable diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658394957440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pre-emptive medicine for hypertension and its prospects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593739614592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Epigenetic Alterations in Podocytes in Diabetic Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206444736768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Metabolic Domino and CKD."},{"@language":"ja","@value":"メタボリックドミノとCKD"},{"@value":"医学と医療の最前線 メタボリックドミノとCKD"},{"@language":"ja-Kana","@value":"イガク ト イリョウ ノ サイゼンセン メタボリックドミノ ト CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206447477632","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"6．メタボリックシンドロームと慢性腎臓病（CKD）"},{"@language":"en","@value":"6. Metabolic Syndrome and Chronic Kidney Disease"},{"@value":"メタボリックシンドロームと慢性腎臓病(CKD)"},{"@language":"ja-Kana","@value":"メタボリックシンドローム ト マンセイ ジンゾウビョウ(CKD)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288124230400","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"14. Metabolic Domino and Pre-emptive Medicine"},{"@language":"ja","@value":"14．メタボリックドミノと先制医療"},{"@value":"教育講演 メタボリックドミノと先制医療"},{"@language":"ja-Kana","@value":"キョウイク コウエン メタボリックドミノ ト センセイ イリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/2051151842060125824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Altered DNA methylation in kidney disease : useful markers and therapeutic targets"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.108.122721"},{"@type":"OPENAIRE","@value":"doi_dedup___::ce722462833d89b853020667a340b9da"},{"@type":"CROSSREF","@value":"10.1038/hr.2011.212_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1038/hr.2016.192_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.2169/naika.100.191_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1097/hjh.0000000000002974_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1172/jci69557_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1016/j.celrep.2019.01.005_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.2169/naika.103.710_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1007/s10157-022-02181-5_references_DOI_5jb2lfnosrAxmw8D9itIHQAb1Qj"},{"@type":"CROSSREF","@value":"10.1038/s41440-018-0081-x_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1038/ki.2015.178_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.1038/s41440-018-0177-3_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.3389/fphar.2021.759299_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"},{"@type":"CROSSREF","@value":"10.2169/naika.107.1913_references_DOI_P1eavKwbpviQuk7r9ZCpo6ZW7dK"}]}